BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 35197539)

  • 21. Antifibrotic Actions of Peroxisome Proliferator-Activated Receptor γ Ligands in Corneal Fibroblasts Are Mediated by β-Catenin-Regulated Pathways.
    Jeon KI; Phipps RP; Sime PJ; Huxlin KR
    Am J Pathol; 2017 Aug; 187(8):1660-1669. PubMed ID: 28606794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA GAS5 suppresses TGF-β1-induced transformation of pulmonary pericytes into myofibroblasts by recruiting KDM5B and promoting H3K4me2/3 demethylation of the PDGFRα/β promoter.
    Wang Y; Chen D; Xie H; Zhou S; Jia M; He X; Guo F; Lai Y; Tang XX
    Mol Med; 2023 Mar; 29(1):32. PubMed ID: 36918759
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evogliptin attenuates bleomycin-induced lung fibrosis via inhibiting TGF-β/Smad signaling in fibroblast.
    Ba YD; Sun JH; Zhao XX
    Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10790-10798. PubMed ID: 33155239
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reversion of in vivo fibrogenesis by novel chromone scaffolds.
    Kim HS; Yoon YM; Meang MK; Park YE; Lee JY; Lee TH; Lee JE; Kim IH; Youn BS
    EBioMedicine; 2019 Jan; 39():484-496. PubMed ID: 30611717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of pirfenidone on proliferation, TGF-β-induced myofibroblast differentiation and fibrogenic activity of primary human lung fibroblasts.
    Conte E; Gili E; Fagone E; Fruciano M; Iemmolo M; Vancheri C
    Eur J Pharm Sci; 2014 Jul; 58():13-9. PubMed ID: 24613900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of GPx4-Regulated Lipid Peroxidation in Idiopathic Pulmonary Fibrosis Pathogenesis.
    Tsubouchi K; Araya J; Yoshida M; Sakamoto T; Koumura T; Minagawa S; Hara H; Hosaka Y; Ichikawa A; Saito N; Kadota T; Kurita Y; Kobayashi K; Ito S; Fujita Y; Utsumi H; Hashimoto M; Wakui H; Numata T; Kaneko Y; Mori S; Asano H; Matsudaira H; Ohtsuka T; Nakayama K; Nakanishi Y; Imai H; Kuwano K
    J Immunol; 2019 Oct; 203(8):2076-2087. PubMed ID: 31534007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis by modulating β-catenin signaling.
    Hu Y; Wang Q; Yu J; Zhou Q; Deng Y; Liu J; Zhang L; Xu Y; Xiong W; Wang Y
    Nat Commun; 2022 Jan; 13(1):114. PubMed ID: 35013220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metformin attenuates lung fibrosis development via NOX4 suppression.
    Sato N; Takasaka N; Yoshida M; Tsubouchi K; Minagawa S; Araya J; Saito N; Fujita Y; Kurita Y; Kobayashi K; Ito S; Hara H; Kadota T; Yanagisawa H; Hashimoto M; Utsumi H; Wakui H; Kojima J; Numata T; Kaneko Y; Odaka M; Morikawa T; Nakayama K; Kohrogi H; Kuwano K
    Respir Res; 2016 Aug; 17(1):107. PubMed ID: 27576730
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Compromised peroxisomes in idiopathic pulmonary fibrosis, a vicious cycle inducing a higher fibrotic response via TGF-β signaling.
    Oruqaj G; Karnati S; Vijayan V; Kotarkonda LK; Boateng E; Zhang W; Ruppert C; Günther A; Shi W; Baumgart-Vogt E
    Proc Natl Acad Sci U S A; 2015 Apr; 112(16):E2048-57. PubMed ID: 25848047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Club cell-specific role of programmed cell death 5 in pulmonary fibrosis.
    Park SY; Hong JY; Lee SY; Lee SH; Kim MJ; Kim SY; Kim KW; Shim HS; Park MS; Lee CG; Elias JA; Sohn MH; Yoon HG
    Nat Commun; 2021 May; 12(1):2923. PubMed ID: 34011956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The matricellular protein CCN1 enhances TGF-β1/SMAD3-dependent profibrotic signaling in fibroblasts and contributes to fibrogenic responses to lung injury.
    Kurundkar AR; Kurundkar D; Rangarajan S; Locy ML; Zhou Y; Liu RM; Zmijewski J; Thannickal VJ
    FASEB J; 2016 Jun; 30(6):2135-50. PubMed ID: 26884454
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Endogenous tryptophan metabolite 5-Methoxytryptophan inhibits pulmonary fibrosis by downregulating the TGF-β/SMAD3 and PI3K/AKT signaling pathway.
    Fang L; Chen H; Kong R; Que J
    Life Sci; 2020 Nov; 260():118399. PubMed ID: 32918977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of Long Noncoding RNA H19 Represses the Progress of Pulmonary Fibrosis through the Transforming Growth Factor β/Smad3 Pathway by Regulating MicroRNA 140.
    Wang X; Cheng Z; Dai L; Jiang T; Jia L; Jing X; An L; Wang H; Liu M
    Mol Cell Biol; 2019 Jun; 39(12):. PubMed ID: 30988156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. tPA promotes the proliferation of lung fibroblasts and activates the Wnt/β-catenin signaling pathway in idiopathic pulmonary fibrosis.
    Chen L; Hou J; Fu X; Chen X; Wu J; Han X
    Cell Cycle; 2019 Nov; 18(22):3137-3146. PubMed ID: 31550972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noncanonical Wnt Signaling Promotes Myofibroblast Differentiation in Pulmonary Fibrosis.
    Liu T; Gonzalez De Los Santos F; Hirsch M; Wu Z; Phan SH
    Am J Respir Cell Mol Biol; 2021 Nov; 65(5):489-499. PubMed ID: 34107237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation.
    Wu D; Lei H; Wang JY; Zhang CL; Feng H; Fu FY; Li L; Wu LL
    J Mol Med (Berl); 2015 Dec; 93(12):1311-25. PubMed ID: 26138247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetraspanin 1 as a mediator of fibrosis inhibits EMT process and Smad2/3 and beta-catenin pathway in human pulmonary fibrosis.
    Liu G; Wang Y; Yang L; Zou B; Gao S; Song Z; Lin Z
    J Cell Mol Med; 2019 May; 23(5):3583-3596. PubMed ID: 30869194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel Mechanisms for the Antifibrotic Action of Nintedanib.
    Rangarajan S; Kurundkar A; Kurundkar D; Bernard K; Sanders YY; Ding Q; Antony VB; Zhang J; Zmijewski J; Thannickal VJ
    Am J Respir Cell Mol Biol; 2016 Jan; 54(1):51-9. PubMed ID: 26072676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Wnt/β-catenin signalling is required for TGF-β/Smad2/3 signalling during myofibroblast proliferation.
    Xu L; Cui WH; Zhou WC; Li DL; Li LC; Zhao P; Mo XT; Zhang Z; Gao J
    J Cell Mol Med; 2017 Aug; 21(8):1545-1554. PubMed ID: 28244647
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
    Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
    Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.